December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
Projections indicate that, the global cell and gene therapy cold chain logistics market will increase from USD 1.89 billion in 2024 to USD 8.06 billion by 2034, experiencing a CAGR of 15.64% over the next 10 years. The cell and gene therapy cold chain logistics market is expanding due to advancing cold chain technologies as well as increasing cell ...
November 01, 2025
Market insights predict, the cell and gene therapy (CGT) pharmaceuticals industry is expected to grow from USD 16.75 billion in 2024 to USD 91.56 billion by 2034, driven by a CAGR of 18.93%. The growing demand for personalized medicine, driving patient-specific therapies, is estimated to drive the growth of the market. North America led the global ...
November 01, 2025
Based on market forecasts, the global cell and gene therapy manufacturing QC market, projected at USD 2.66 billion in 2024, is expected to reach USD 12.35 billion by 2034, growing at a CAGR of 16.89% over the forecast period. The growing demand for cell and gene therapy and stringent regulatory policies drive the global market. North America domina...
November 01, 2025
According to forecasts, the global cell and gene therapy bioassay services market will grow from USD 5.05 billion in 2024 to USD 16 billion by 2034, with an expected CAGR of 12.24%. A rise in personalized trends is expanding the global market development. North America dominated the market due to the growing focus on the growth of specialized bioan...
November 01, 2025
Market insights predict the global orthopedic 3D printing devices industry will increase from USD 1.28 billion in 2024 to USD 6.87 billion by 2034, achieving a CAGR of 11.24%. The market is growing due to rising demand for personalized implants, faster prototyping, and cost-effective surgical solutions. North America is dominating the market due to...
November 01, 2025
Market insights predict, the cartilage repair industry is expected to grow from USD 1.51 billion in 2024 to USD 7.32 billion by 2034, driven by a CAGR of 17.14%. The cartilage repair market is growing due to the rising geriatric population. North America’s dominance can be attributed to the rising cases of injuries in adults....
November 01, 2025
According to market projections, the viral vector-based cell & gene therapy CDMO sector is expected to grow from USD 142.77 million in 2024 to USD 497.7 million by 2034, reflecting a CAGR of 13.44%. The key benefits of collaborating with a viral vector CDMO including therapeutic development and clinical trials drive the expansion of these organ...
November 01, 2025
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing demand for personalized medicines bolster market growth. The availability of state-of-the-art resear...
November 01, 2025
Market insights predict, the gene knockdown stable cell line service industry is expected to grow from USD 715 million in 2024 to USD 1557 million by 2034, driven by a CAGR of 8.16%. The market is growing due to the increasing use of stable cell models in drug development, target validation, and functional genomics studies. The strong biotech resea...
November 01, 2025
Based on market forecasts, the global cell and gene therapy tools and reagents market, projected at USD 10.04 billion in 2024, is expected to reach USD 27.3 billion by 2034, growing at a CAGR of 10.76% over the forecast period. The cell and gene therapy tools and reagents market is expanding due to growing CGT clinical trials as well as growing res...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com